IShares Medical Financial Statements From 2010 to 2024
| IHI Etf | USD 60.35 0.05 0.08% |
Check IShares Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IShares Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . IShares financial statements analysis is a perfect complement when working with IShares Medical Valuation or Volatility modules.
IShares |
iShares Medical Devices ETF Price To Sales Analysis
IShares Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current IShares Medical Price To Sales | 3.38 X |
Most of IShares Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iShares Medical Devices is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
IShares Medical Price To Sales Component Assessment
Based on the latest financial disclosure, iShares Medical Devices has a Price To Sales of 3.38 times. This is much higher than that of the iShares family and 27.79% higher than that of the Health category. The price to sales for all United States etfs is notably lower than that of the firm.
iShares Medical Devices Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IShares Medical's current stock value. Our valuation model uses many indicators to compare IShares Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IShares Medical competition to find correlations between indicators driving IShares Medical's intrinsic value. More Info.iShares Medical Devices is considered the top ETF in price to earning as compared to similar ETFs. It also is considered the top ETF in price to book as compared to similar ETFs fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for iShares Medical Devices is roughly 7.97 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IShares Medical's earnings, one of the primary drivers of an investment's value.About IShares Medical Financial Statements
Investors use fundamental indicators, such as IShares Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although IShares Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
The fund will invest at least 80 percent of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. US Medical is traded on NYSEARCA Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether iShares Medical Devices offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Medical Devices Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Medical Devices Etf:Check out the analysis of IShares Medical Correlation against competitors. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
The market value of iShares Medical Devices is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Medical's value that differs from its market value or its book value, called intrinsic value, which is IShares Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Medical's market value can be influenced by many factors that don't directly affect IShares Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.